8-KLeadership ChangesExhibits & Filings

DEXCOM INC 8-K Report, Executive Changes (Nov 23, 2009)

Filed November 23, 2009For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on November 23, 2009, reporting a significant change in its Board of Directors. Effective November 20, 2009, Nicholas Augustinos was appointed as a Class I director, with his term set to expire in 2012. This appointment is a key development for the company's governance structure. Mr. Augustinos' compensation as a non-employee director is structured around equity incentives. He will receive an annual retainer in the form of stock options, an initial stock option grant valued at $300,000 that vests over 36 months, and an additional annual stock option grant valued at $125,000 vesting over 12 months. These grants are designed to align director interests with long-term shareholder value and reflect the company's commitment to attracting experienced leadership. The company also attached a press release dated November 23, 2009, detailing this appointment.

Key Highlights

  • 1Appointment of Nicholas Augustinos as a Class I Director, effective November 20, 2009, with a term expiring in 2012.
  • 2Mr. Augustinos is expected to join the Nominating and Governance Committee.
  • 3Non-employee director compensation includes an annual retainer via an option grant ($30,000 Black-Scholes value).
  • 4An initial stock option grant to Mr. Augustinos valued at $300,000 (Black-Scholes value), vesting over 36 months.
  • 5Additional annual stock option grants for Mr. Augustinos valued at $125,000 (Black-Scholes value), vesting over 12 months.
  • 6All option grants have an exercise price equal to the fair market value on the date of grant.
  • 7A press release regarding the appointment was issued on November 23, 2009, and attached as an exhibit.

Frequently Asked Questions

Nicholas Augustinos has been appointed as a Class I director to DexCom's Board of Directors. While the 8-K doesn't detail his specific background, the appointment suggests the company is seeking to enhance its board's expertise and governance. He is expected to serve on the Nominating and Governance Committee.

Mr. Augustinos will receive standard non-employee director compensation. This includes an annual retainer in the form of stock options, an initial substantial stock option grant that vests over three years, and an additional annual stock option grant that vests over one year. The exercise price for all options is set at the fair market value on the grant date.

The primary financial impact relates to the dilutive effect of the stock options granted to Mr. Augustinos. The Black-Scholes values indicate a potential future equity dilution. However, the compensation structure is typical for attracting and retaining experienced directors and aims to align their interests with long-term shareholder value.

In a classified board structure, directors are divided into classes (typically three), with each class elected for a staggered term. A Class I director, like Mr. Augustinos, has a term that is set to expire in a particular year (2012 in this case), meaning not all board seats are up for election simultaneously. This structure is intended to provide board continuity.